MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome

Journal of Human Reproductive Sciences

Volumn 5, Issue 1, 2012, Pages 52-56

  Jain, Madhu ^a   Pandey, Priyanka ^a   Tiwary, Narendra ^a   Jain, Shuchi ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

CAD; coronary artery disease; hyperlipidemia; MTHFR C677T polymorphism; PCOS; polycystic ovary syndrome

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MTHFR C677T GENE; OVARY POLYCYSTIC DISEASE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84863693945     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.97802     Document Type: Article

References (43)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-61.
2. Adams J, Polson DW, Abdulwahid N, Morris DV, Franks S, Mason HD, et al. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985;1375-8.
3. Hull MG. Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol Endocrinol 1987;1:235-45.
4. Legro RS. Polycystic ovary syndrome and cardiovascular disease: A premature association? Endocr Rev 2003;24:302-12.
5. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 2003;52:908-15.
6. Talbott EO, Zborowskii JV, Boudraux MY. Do women with polycystic ovary Syndrome have an increased risk of cardiovascular disease? Review of the evidence. Minerva Ginecol 2004;56:27-39.
7. Huang L, Song XM, Zhu WL, Li Y. Plasma Homocysteine and Gene Polymorphisms Associated with the Risk of Hyperlipidemia in Northern Chinese Subjects. Biomed Environ Sci 2008;21:514-20.
8. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
9. Giltay EJ, Hoogeven EK, Elbers J, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects [letter]. Atherosclerosis 1998;139:197-8.
10. De Pergola G, Pannacciulli N, Zamboni M, Minenna A, Brocco G, Sciaraffia M. Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese premenopausal women. Diabetes Nutr Metab 2001;14:253-8.
11. Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT. Hormonal regulation of cystathionine-synthase expression in liver. J Biol Chem 2002;26:278-82.
12. Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002;13:75-9.
13. Badawy A, State O, El Gawad SSh, El Aziz OA. Plasma homocysteine and polycystic ovary syndrome: The missed link. Eur J Obstet Gynecol Reprod Biol 2007;131:68-72.
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
15. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-53.
16. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:95-201.
17. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 2002;99:5606-11.
18. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.
19. Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat Res 2001;475:57-67.
20. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000;279:F671-8.
21. Romerio SC, Linder L, Nyfeler J, Wenk M, Litynsky P, Asmis R, et al. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. Atherosclerosis 2004;176:337-44.
22. Starkebaum G, Harlan JM. Endothelial cell injury due to coppercatalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6.
23. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27-36.
24. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobson D. Homocysteine induces expression and secretion of monocyte chemo attractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation 2001;103:2717-23.
25. Szymanski W, Kazdepka-Zieminska A. Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity. Ginekol Pol 2003;74:1392-6.
26. Willmott M, Bartosik DB, Romanoff EB. The effect of folic acid on superovulation in the immature rat. J Endocrinol 1968;41:439-45.
27. Mohanty D, Das KC. Effect of folate deficiency on the reproductive organs of female rhesus monkeys: A cytomorphological and cytokinetic study. J Nutr 1982;112:1565-76.
28. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukulmez O, Akgul E, et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001;76:511-6.
29. Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest 2002;53:157-62.
30. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;18:721-7.
31. Vrbikova J, Tallova J, Bicikova M, Dvorakova K, Hill M, Starka L. Plasma thiols and androgen levels in polycystic ovary syndrome. Clin Chem Lab Med 2003;41:216-21.
32. Bayraktar F, Dereli D, Ozgen AG, Yilmaz C. Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. Endocr J 2004;51:601-8.
33. Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, Belchetz PE. Plasma homocysteine in polycystic ovary syndrome: Does it correlate with insulin resistance and ethnicity? Clin Endocrinol (Oxf) 2004;60:560-7.
34. Kilic-Okman T, Guldiken S, Kucuk M. Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome. Endocr J 2004;51:505-8.
35. Yilmaz M, Biri A, Bukan N, Karakoc A, Sancak B, Toruner F, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258-63.
36. Tsanadis G, Vartholomatos G, Korkontzelos I, Avgoustatos F, Kakosimos G, Sotiriadis A, et al. Polycystic ovarian syndrome and thrombophilia. Hum Reprod 2002;17:314-9.
37. Orio F Jr, Palomba S, Di Biase S, Colao A, Tauchmanova L, Savastano S, et al. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:673-9.
38. Choi SW, Gu BH, Ramakrishna S, Park JM, Baek KH. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2009;145:85-8.
39. Karadeniz M, Erdogan M, Zengi A, Eroglu Z, Tamsel S, Olukman M, et al. Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome. Endocrine 2010;38:127-33.
40. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Working Group 2004. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
41. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol 1961;21:1440-7.
42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
43. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.